Ionis Pharmaceuticals (IONS) Stock Price, Quote, News & History | Benzinga

Ionis Pharmaceuticals Inc (IONS) Stock Price, Quote, News & History

IONSNASDAQ

Trade with Public

Trade with Public

$62.04

2.303.85%

At close: Aug 24, 5:00 PM EST

$61.90

-0.14-0.23%

After Hours: 6:12 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$60.54

Close

$62.04

Volume / Avg.

2.21M / 2.88M

Day Range

$59.70 - $62.07

52 Wk Range

41.71 - 86.74

Market Cap

$10.29B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

17.11%

Days to Cover

6.35

Recent Ionis Pharmaceuticals, Inc. News

This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Wall Street analysts changed outlook on top names. Check all rating changes, including upgrades/downgrades, on Benzinga analyst ratings page.

Avi Kapoor

This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Wall Street analysts upgraded PGR, MRK, EPR and initiated coverage on BEKE and IONS. Check analyst ratings and price targets for these stocks.

Avi Kapoor

This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts updated ratings on SPHR, CVLG, MIST, MSGE,. Check out analyst ratings page for full details and stock recommendations.

Avi Kapoor

This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.

Avi Kapoor

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top analysts change outlook on ALNY, AGMB, BMRN, BEKE, and IONS with ratings and price targets. Check out opinions and coverage on Benzinga.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-496.43M

Investing Cash Flow (TTM)

232.15M

Financing Cash Flow (TTM)

317.36M

Free Cash Flow (TTM)

-567.50M

Capital Expenditure (TTM)

-71.07M

Net Change in Cash (TTM)

53.07M

Analyst Trends and Forecast

7

Apr

1

May

5

1

Jun

11

Jul

1

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.49B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.15

PB Ratio (TTM)

22.58

Earnings Yield % (TTM)

-5.83%

Earnings Yield % (FWD)

-6.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.65

Company Debt

Total Debt

$1.35B

LT Debt

$1.35B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$700.33M

Total Cash

$350.07M

Debt to Equity

3.67

Issuance of Debt (TTM)

$69.67M

Repayment of Debt (TTM)

-$700.33M

Key Statistics

Open

$60.54

Close

$62.04

Volume / Avg.

2.21M / 2.88M

Day Range

$59.70 - $62.07

52 Wk Range

41.71 - 86.74

Market Cap

$10.29B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

17.11%

Days to Cover

6.35

About

Sector

Health Care

Industry

Biotechnology

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Ionis Pharmaceuticals (IONS) stock?

A

You can purchase shares of Ionis Pharmaceuticals (NASDAQ:IONS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ionis Pharmaceuticals (IONS) competitors?

A

Other companies in Ionis Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Ionis Pharmaceuticals (IONS) stock?

A

Ionis Pharmaceuticals has a consensus price target of $87.44.

Q

What is the current price for Ionis Pharmaceuticals (IONS)?

A

The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $61.9 last updated August 24, 2026 at 6:12 PM EDT.

Q

Does Ionis Pharmaceuticals (IONS) pay a dividend?

A

There are no upcoming dividends for Ionis Pharmaceuticals.

Q

When is Ionis Pharmaceuticals (NASDAQ:IONS) reporting earnings?

A

Ionis Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Ionis Pharmaceuticals (IONS) going to split?

A

There is no upcoming split for Ionis Pharmaceuticals.

Q

What sector and industry does Ionis Pharmaceuticals (IONS) operate in?

A

Ionis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.